The Medication(s) listed below have been approved by the Food & Drug Administration (FDA) as orphan products for treatment of this condition. There may be other products available
that are not considered orphan products.
Lepirudin (Brand name: Refluden)
- Manufactured by
Hoechst Marion Roussel
FDA-approved indication: For anticoagulation in patients with heparin-induced thrombocytopenia and associated thromboembolic disease in order to prevent further thromboembolic complications.
National Library of Medicine Drug Information Portal